Skip to Main Content

Author Details

Gert De Meerleer
University Hospitals Leuven
1997
186
45
PMIDPaper TitleJournal TitlePublished Year
37537111Impact of the Standardization of Penile Cancer Care on the Quality of Care, Outcomes, and Academic-driven Centralization in a Single eUROGEN Referral Center.Eur Urol Focus2024
36154809Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER Trial.Eur Urol Focus2023
38068715The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.Nutrients2023
37945903Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.Nat Genet2023
37739609How High Should We Go for Para-aortic Lymph Node Radiation Therapy?Int J Radiat Oncol Biol Phys2023
37117107Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.Eur Urol2023
36997468Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab: A Retrospective Analysis.Clin Genitourin Cancer2023
36813168ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer.Radiother Oncol2023
36878753Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy.Eur Urol Oncol2023
36305586Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy.Int J Urol2023
36167599ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer.Eur Urol2023
34893458Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial.Eur Urol Focus2022
35507060[<sup>18</sup>F]PSMA-1007 PET/CT in the detection of neoplastic lumbosacral plexopathy as an emerging and underestimated spread of prostate cancer.Eur J Nucl Med Mol Imaging2022
35641399Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer.Eur Urol Oncol2022
35569470Postoperative Radiation Therapy in Prostate Cancer: Timing, Duration of Hormonal Treatment and the Use of PSMA PET-CT.Int J Radiat Oncol Biol Phys2022
36001857Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.J Clin Oncol2022
36354270Post-prostatectomy radiotherapy: does late toxicity lead the game?BJU Int2022
36387203High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer.Front Oncol2022
35947520Editorial Comment.J Urol2022
31558422Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate Cancer.Eur Urol Oncol2021
35929921Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma.Turk J Urol2021
33844128A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy.Clin J Gastroenterol2021
33637464Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review.Eur Urol Oncol2021
33580296Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review.World J Urol2021
33929626Parameters predicting [<sup>18</sup>F]PSMA-1007 scan positivity and type and number of detected lesions in patients with biochemical recurrence of prostate cancer.EJNMMI Res2021
34526701Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer.Nat Rev Urol2021
34663254Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.BMC Cancer2021
34339655Elective nodal radiotherapy in prostate cancer.Lancet Oncol2021
34089682In Regard to Zelefsky et al.Int J Radiat Oncol Biol Phys2021
34049848Is the Age of Extended Pelvic Lymph Node Dissection Over? The Devil Is in the Details.Eur Urol Oncol2021
31810893Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy.Eur Urol Oncol2021
33225759Current and emerging therapies for localized high-risk prostate cancer.Expert Rev Anticancer Ther2021
33398198Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
33473200Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.Nat Genet2021
32943378Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration.Eur Urol Oncol2021
32417995Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by <sup>68</sup>Ga-PSMA-11 PET/CT or <sup>11</sup>C-Choline PET/CT: impact of postoperative treatments.World J Urol2021
32221712Correction to: Metastasectomy for visceral and skeletal oligorecurrent prostate cancer.World J Urol2020
31718396Development and External Validation of a Multiparametric Magnetic Resonance Imaging and International Society of Urological Pathology Based Add-On Prediction Tool to Identify Prostate Cancer Candidates for Pelvic Lymph Node Dissection.J Urol2020
31947974A Trial-Based Cost-Utility Analysis of Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer.Cancers (Basel)2020
32035581Salvage Radiotherapy for Prostate Cancer.Clin Oncol (R Coll Radiol)2020
33224007Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration.Curr Urol2020
33178576A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort.Front Oncol2020
32823690Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy.Cancers (Basel)2020
32676413Metastasectomy of oligometastatic urothelial cancer: a single-center experience.Transl Androl Urol2020
32666822Long- versus short-term androgen deprivation therapy with high-dose radiotherapy for biochemical failure after radical prostatectomy: a randomized controlled trial.Future Oncol2020
32448171Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial.BMC Cancer2020
32211317Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis.Front Oncol2020
32384918Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases.BMC Cancer2020
32565889Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news.Ecancermedicalscience2020
30406289Patient- versus physician-reported outcomes in prostate cancer patients receiving hypofractionated radiotherapy within a randomized controlled trial.Strahlenther Onkol2019
  • 1 - 50 of 186

Recommended Authors

Soumyajit Roy
Rush University Medical Center
Career Start Year 2013
Number of shared co-authors 8
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 13
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Career Start Year 2010
Number of shared co-authors 42
Alan Dal Pra
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 21
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 2
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 20
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 11
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 20
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 19
Andrew K Lee
Texas Center for Proton Therapy
Career Start Year 2001
Number of shared co-authors 2
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 17
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 18
Mark K Buyyounouski
Stanford University
Career Start Year 1999
Number of shared co-authors 14
Wolfgang Lilleby
Oslo University Hospital
Career Start Year 1999
Number of shared co-authors 18
Robert B Den
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 30
Eric Vigneault
Centre Hospitalier Universitaire de Quebec
Career Start Year 1997
Number of shared co-authors 10
Eric M Horwitz
Fox Chase Cancer Center
Career Start Year 1996
Number of shared co-authors 24
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 24
Almudena Zapatero
University Hospital La Princesa
Career Start Year 1995
Number of shared co-authors 26
Jay P Ciezki
Cleveland Clinic
Career Start Year 1995
Number of shared co-authors 17
Xavier Maldonado
Hospital Universitari Vall d'Hebron
Career Start Year 1994
Number of shared co-authors 16
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 4
William Robert Lee
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 13
Patrick A Kupelian
university of california los angeles Medical Center
Career Start Year 1993
Number of shared co-authors 22
Thomas M Pisansky
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 27
Richard Choo
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 13
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 22
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 14
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 28
Alan Pollack
University of Miami Miller School of Medicine
Career Start Year 1963
Number of shared co-authors 25

Collaborators

Piet Ost
Ghent University, GZA Ziekenhuizen
Co-authored papers 81
Hendrik Van Poppel
University Hospitals Leuven
Co-authored papers 22
Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 16
Robert Jeffrey Karnes
Mayo Clinic
Co-authored papers 10
Catharine M L West
University of Manchester
Co-authored papers 8
Alison M Dunning
Co-authored papers 7
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 6
Sune F Nielsen
Co-authored papers 6
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 6
David V Conti
Co-authored papers 6
Tokhir Dadaev
The Institute of Cancer Research
Co-authored papers 6
Maria Elena Martinez
Co-authored papers 6
Kay-Tee Khaw
Co-authored papers 6
Guido Jenster
Erasmus University Medical Center
Co-authored papers 6
Stephen J Chanock
National Cancer Institute, National Institutes of Health
Co-authored papers 6
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 6
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 6
Stephanie J Weinstein
Co-authored papers 6
Sue A Ingles
Co-authored papers 6
Shannon K McDonnell
Mayo Clinic
Co-authored papers 6
Børge G Nordestgaard
Co-authored papers 6
Demetrius Albanes
Co-authored papers 6
Gerald L Andriole
Co-authored papers 6
Christopher A Haiman
University of Southern California
Co-authored papers 6
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 6
Kathryn L Penney
Co-authored papers 6
Judith A Clements
Co-authored papers 6
Elio Riboli
Co-authored papers 6
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 6
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 6
Release 1.2